Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| CHEBI_21211 | CHEBI_21211 | |
| L-4'-bromophenylalanine | CHEBI_21212 | |
| CHEBI_21213 | CHEBI_21213 | |
| CHEBI_21214 | CHEBI_21214 | |
| CHEBI_21215 | CHEBI_21215 | |
| CHEBI_21216 | CHEBI_21216 | |
| TRISACETYLACETONATOCHROMIUM(III) | CHEBI_35851 | |
| tris(acetylacetonato)chromium | CHEBI_33035 | |
| transplatin | CHEBI_35852 | [A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a trans planar configuration around the central platinum ion. Unlike its cis-isomer, cisplatin, it does not exhibit any useful pharmacological effect and is toxic.] |
| diamminedichloroplatinum | CHEBI_51214 | |
| CHEBI_35853 | CHEBI_35853 | |
| valacyclovir | CHEBI_35854 | |
| hydroxidooxidosulfidosulfate(1-) | CHEBI_35945 | |
| thiosulfite(1-) | CHEBI_35944 | |
| dioxidosulfanidosulfate(1-) | CHEBI_35943 | |
| EC 2.5.1.9 (riboflavin synthase) inhibitor | CHEBI_60901 | [An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that inhibits the action of riboflavin synthase (EC 2.5.1.9).] |
| N-[6-amino-1-(2-methylpropyl)-2,4-dioxo-5-pyrimidinyl]-2-(2-methylphenoxy)-N-(2-methylpropyl)acetamide | CHEBI_106058 | |
| N-[(2R,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide | CHEBI_131014 | |
| orphenadrine hydrochloride | CHEBI_60902 | [A hydrochloride comprising equimolar amounts of ophenadrine and hydrogen chloride.] |
| orphenadrine | CHEBI_7789 | [A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.] |